Genprex (GNPX) AI Stock Analysis

Top Page

Genprex

(NASDAQ:GNPX)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Genprex (GNPX) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $1.13M
Dividend Yield: ―
Average Volume (3M): 283.06K
Price to Earnings (P/E): -0.0
Beta (1Y): -0.37
Revenue Growth: ―
EPS Growth: 93.08%
Country: US
Employees: 13
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Genprex Business Overview & Revenue Model

Company Description

Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leadi...

Genprex Risk Analysis

Genprex disclosed 69 risk factors in its most recent earnings report. Genprex reported the most risks in the "Tech & Innovation" category.

Tech & Innovation - Risks related to the company’s reliance on technology and ability to make innovative products

Latest Risks Added

0 New Risks

Genprex Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GNPX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
KZIA	42Neutral	$97.13M	-1.17	-116.86%	―	-98.25%	76.83%
BOLT	40Underperform	$12.69M	-0.41	-126.23%	―	12.79%	37.93%
INTS	39Underperform	$11.10M	-0.70	-116.61%	―	―	76.63%

* Healthcare Sector Average

Performance Comparison

GNPX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GNPX	Genprex	2.24	-114.36	-98.08%
KZIA	Kazia Therapeutics Limited	8.50	0.75	9.68%
BOLT	Bolt Biotherapeutics, Inc.	6.59	1.01	18.10%
INTS	Intensity Therapeutics, Inc.	3.40	-12.10	-78.06%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Genprex AI Stock Analysis